FDA Lifts Cloud Over J&J’s Xarelto With ROCKET-AF Re-Analysis

Agency reaffirms safety and efficacy in atrial fibrillation patients despite use of faulty coagulation monitoring device in pivotal trial led by current FDA Commissioner Robert Califf when he was at Duke University.